Source:http://linkedlifedata.com/resource/pubmed/id/15791505
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2005-3-25
|
pubmed:abstractText |
Fluoroquinolone prophylaxis during neutropenia in patients with cancer has been associated with decreased incidence of gram-negative bacteremia. Bacterial antimicrobial resistance is likely to cause a progressive lack of efficacy of fluoroquinolones, but no convincing evidence from clinicoepidemiologic observations has proved this hypothesis.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1537-6591
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1087-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15791505-Amyloidosis,
pubmed-meshheading:15791505-Anemia, Aplastic,
pubmed-meshheading:15791505-Anti-Bacterial Agents,
pubmed-meshheading:15791505-Antibiotic Prophylaxis,
pubmed-meshheading:15791505-Bacterial Infections,
pubmed-meshheading:15791505-Humans,
pubmed-meshheading:15791505-Leukemia,
pubmed-meshheading:15791505-Lymphoma,
pubmed-meshheading:15791505-Middle Aged,
pubmed-meshheading:15791505-Multiple Myeloma,
pubmed-meshheading:15791505-Neutropenia,
pubmed-meshheading:15791505-Ofloxacin
|
pubmed:year |
2005
|
pubmed:articleTitle |
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
|
pubmed:affiliation |
Section of Infectious Diseases and Clinical Immunology, Department of Internal Medicine III, University Hospital of Ulm, Germany. stefan.reuter@medizin.uni-ulm.de
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|